Natera, Inc.
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30206% above fair value
$378.92−35.38 (-8.54%)
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera Stock Options Outstanding by Quarter
Stock Options Outstanding — Weighted-Average Exercise Price ($/sh) ($)
Natera Stock Options Outstanding: $29.28 in Q2 2026, down 4.1% from a year earlier.
Latest, Q2 2026
29.28
Period ended Jun 30, 2026
Change on a year earlier
-4.1%
30.54 in Q2 2025
History
35 quarters
Since Q4 2017
Sources
34
Documents cited below
Where the Q2 2026 figure comes from
Source: Form 10-Q (2026-08-07) ↗
Reported in Form 10-K/10-Q Note — Stock-Based Compensation (XBRL).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Stock Options Outstanding — Weighted-Average Exercise Price ($/sh) ($) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 29.28 | -4.1% | Form 10-Q (2026-08-07) ↗ |
| Q1 2026 | Mar 31, 2026 | 28.77 | -5.6% | Form 10-Q (2026-05-08) ↗ |
| Q4 2025 | Dec 31, 2025 | 27.03 | -10.6% | Form 10-Q (2026-08-07) ↗ |
| Q3 2025 | Sep 30, 2025 | 30.55 | +6.6% | Form 10-Q (2025-11-07) ↗ |
| Q2 2025 | Jun 30, 2025 | 30.54 | +11.3% | Form 10-Q (2025-08-08) ↗ |
| Q1 2025 | Mar 31, 2025 | 30.47 | +16.1% | Form 10-Q (2025-05-09) ↗ |
| Q4 2024 | Dec 31, 2024 | 30.22 | +27.8% | Form 10-K (2026-02-27) ↗ |
| Q3 2024 | Sep 30, 2024 | 28.67 | +21.6% | Form 10-Q (2024-11-12) ↗ |
| Q2 2024 | Jun 30, 2024 | 27.45 | +19.9% | Form 10-Q (2024-08-09) ↗ |
| Q1 2024 | Mar 31, 2024 | 26.25 | +15.7% | Form 10-Q (2024-05-10) ↗ |
| Q4 2023 | Dec 31, 2023 | 23.65 | +12.0% | Form 10-K (2025-02-28) ↗ |
| Q3 2023 | Sep 30, 2023 | 23.57 | +12.0% | Form 10-Q (2023-11-09) ↗ |
| Q2 2023 | Jun 30, 2023 | 22.89 | +9.0% | Form 10-Q (2023-08-04) ↗ |
| Q1 2023 | Mar 31, 2023 | 22.69 | +9.5% | Form 10-Q (2023-05-10) ↗ |
| Q4 2022 | Dec 31, 2022 | 21.11 | +20.4% | Form 10-K (2024-02-29) ↗ |
| Q3 2022 | Sep 30, 2022 | 21.04 | +21.1% | Form 10-Q (2022-11-09) ↗ |
| Q2 2022 | Jun 30, 2022 | 21 | +21.7% | Form 10-Q (2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 20.73 | +47.1% | Form 10-Q (2022-05-06) ↗ |
| Q4 2021 | Dec 31, 2021 | 17.54 | +56.7% | Form 10-K (2023-03-01) ↗ |
| Q3 2021 | Sep 30, 2021 | 17.37 | +52.5% | Form 10-Q (2021-11-05) ↗ |
| Q2 2021 | Jun 30, 2021 | 17.25 | +53.2% | Form 10-Q (2021-08-06) ↗ |
| Q1 2021 | Mar 31, 2021 | 14.09 | +27.3% | Form 10-Q (2021-05-07) ↗ |
| Q4 2020 | Dec 31, 2020 | 11.19 | +7.7% | Form 10-K (2022-02-25) ↗ |
| Q3 2020 | Sep 30, 2020 | 11.39 | +10.9% | Form 10-Q (2020-11-06) ↗ |
| Q2 2020 | Jun 30, 2020 | 11.26 | +13.7% | Form 10-Q (2020-08-07) ↗ |
| Q1 2020 | Mar 31, 2020 | 11.07 | +18.1% | Form 10-Q (2020-05-08) ↗ |
| Q4 2019 | Dec 31, 2019 | 10.39 | +35.1% | Form 10-K (2021-02-26) ↗ |
| Q3 2019 | Sep 30, 2019 | 10.27 | +40.5% | Form 10-Q (2019-11-08) ↗ |
| Q2 2019 | Jun 30, 2019 | 9.90 | +43.5% | Form 10-Q (2019-08-09) ↗ |
| Q1 2019 | Mar 31, 2019 | 9.37 | +38.6% | Form 10-Q (2019-05-10) ↗ |
| Q4 2018 | Dec 31, 2018 | 7.69 | +17.6% | Form 10-K (2020-03-02) ↗ |
| Q3 2018 | Sep 30, 2018 | 7.31 | – | Form 10-Q (2018-11-09) ↗ |
| Q2 2018 | Jun 30, 2018 | 6.90 | – | Form 10-Q (2018-08-09) ↗ |
| Q1 2018 | Mar 31, 2018 | 6.76 | – | Form 10-Q (2018-03-31) ↗ |
| Q4 2017 | Dec 31, 2017 | 6.54 | – | Form 10-K (2019-03-15) ↗ |
Cite this data
StockData. (2026). Natera Stock Options Outstanding ($), quarterly Q4 2017–Q2 2026 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/equity-options-outstanding-waep
See every metric in the Natera KPI table. Data updated Nov 2, 2026.